We also explored the clinical and histopathological features of patients with positive PD-L1 expression, including SCC, poor differentiation, advanced stage, large tumor size, concomitant HPV infection, history of multiple parity and abortion, and previous history of receiving chemotherapy, who were also potential beneficiaries from PD-1/PD-L1 inhibitors. Here, CD274 is linked to neoplasm.